SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001607062-15-000325
Filing Date
2015-07-17
Accepted
2015-07-17 16:04:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1 gnbt71515forms1.htm S-1 2350435
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 10066
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2758
4 EXHIBIT 32.2 ex23_2.htm EX-32.2 6069
11 GRAPHIC image_001.gif GRAPHIC 4400
12 GRAPHIC image_001.jpg GRAPHIC 6647
  Complete submission text file 0001607062-15-000325.txt   7798365

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20140731.xml EX-101.INS 1075439
6 XBRL SCHEMA FILE gnbt-20140731.xsd EX-101.SCH 75403
7 XBRL CALCULATION FILE gnbt-20140731_cal.xml EX-101.CAL 63795
8 XBRL DEFINITION FILE gnbt-20140731_def.xml EX-101.DEF 268193
9 XBRL LABEL FILE gnbt-20140731_lab.xml EX-101.LAB 450164
10 XBRL PRESENTATION FILE gnbt-20140731_pre.xml EX-101.PRE 415067
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: S-1 | Act: 33 | File No.: 333-205724 | Film No.: 15993861
SIC: 2834 Pharmaceutical Preparations